Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

300.00p
   
  • Change Today:
      13.00p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 325,249
  • Market Cap: £300.00m
  • RiskGrade: 125

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
90.26% below the market average90.26% below the market average90.26% below the market average90.26% below the market average90.26% below the market average
75.76% below the sector average75.76% below the sector average75.76% below the sector average75.76% below the sector average75.76% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
12.21% above the market average12.21% above the market average12.21% above the market average12.21% above the market average12.21% above the market average
3.7% below the sector average3.7% below the sector average3.7% below the sector average3.7% below the sector average3.7% below the sector average
Price Book Ratio
70.91% below the market average70.91% below the market average70.91% below the market average70.91% below the market average70.91% below the market average
43.48% below the sector average43.48% below the sector average43.48% below the sector average43.48% below the sector average43.48% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
97.02% above the market average97.02% above the market average97.02% above the market average97.02% above the market average97.02% above the market average
96.36% above the sector average96.36% above the sector average96.36% above the sector average96.36% above the sector average96.36% above the sector average
Price Chg 3m
96.18% above the market average96.18% above the market average96.18% above the market average96.18% above the market average96.18% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
90.42% above the market average90.42% above the market average90.42% above the market average90.42% above the market average90.42% above the market average
84.00% above the sector average84.00% above the sector average84.00% above the sector average84.00% above the sector average84.00% above the sector average
Momentum 20
93.75% above the market average93.75% above the market average93.75% above the market average93.75% above the market average93.75% above the market average
92.00% above the sector average92.00% above the sector average92.00% above the sector average92.00% above the sector average92.00% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
80.57% below the market average80.57% below the market average80.57% below the market average80.57% below the market average80.57% below the market average
11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
98.62% below the market average98.62% below the market average98.62% below the market average98.62% below the market average98.62% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
20.09% above the market average20.09% above the market average20.09% above the market average20.09% above the market average20.09% above the market average
41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average
Operating Profit Loss
97.41% below the market average97.41% below the market average97.41% below the market average97.41% below the market average97.41% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
48.01% above the market average48.01% above the market average48.01% above the market average48.01% above the market average48.01% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Cash
68.53% above the market average68.53% above the market average68.53% above the market average68.53% above the market average68.53% above the market average
72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
62.93% above the market average62.93% above the market average62.93% above the market average62.93% above the market average62.93% above the market average
58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
76.66% below the market average76.66% below the market average76.66% below the market average76.66% below the market average76.66% below the market average
88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average
Brokers Percent Neutral
73.70% above the market average73.70% above the market average73.70% above the market average73.70% above the market average73.70% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 300.00p
Change Today 13.00p
% Change 4.53 %
52 Week High 470.00
52 Week Low 166.80
Volume 325,249
Shares Issued 100.00m
Market Cap £300.00m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.48% below the market average25.48% below the market average25.48% below the market average25.48% below the market average25.48% below the market average
13.73% above the sector average13.73% above the sector average13.73% above the sector average13.73% above the sector average13.73% above the sector average
Price Trend
19.06% below the market average19.06% below the market average19.06% below the market average19.06% below the market average19.06% below the market average
41.82% above the sector average41.82% above the sector average41.82% above the sector average41.82% above the sector average41.82% above the sector average
Income Not Available
Growth
52.27% below the market average52.27% below the market average52.27% below the market average52.27% below the market average52.27% below the market average
54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 6
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 02-May-2024

Time Volume / Share Price
16:39 35,562 @ 298.33p
16:35 50,193 @ 300.00p
16:35 255 @ 300.00p
16:35 1,428 @ 300.00p
16:35 378 @ 300.00p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page